CG:600812 North China Pharmaceutical Company. Ltd

North China Pharmaceutical Company. Ltd is a China-based company principally engaged in the production and distribution of pharmaceuticals. The Company's main products are classified as penicillin, cephalosporin, vitamin and other products, including bulk pharmaceuticals, finish preparations and healthcare products, among others, which are applied in the treatment of nephropathy, diabetes and others. In addition, it is involved in the provision of anti-infection active pharmaceutical ingredients, as well as trading of pharmaceuticals and others. The Company distributes its products in domestic market and to overseas markets.

12.59 CNY
As of 01/17/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Unknown
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  01/03/2000
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   20,863,277,056 CNY
Current dividend yield:   0.23%
Sedol:      

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy